Finally, the present study illustrated the inverse correlation of vaspin serum levels with most cardio-metabolic risk profiles in patients with acute coronary syndromes not treated with rosuvastatin, compared to rosuvastatin-treated patients. Here, SERPINA12 is linked to acute coronary syndrome.